PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients- A Post-Hoc Analysis of Il-28B Subgroup
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1318
https://www.valueinhealthjournal.com/article/S1098-3015(12)01383-6/fulltext
Title :
PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients- A Post-Hoc Analysis of Il-28B Subgroup
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01383-6&doi=10.1016/j.jval.2012.03.1318
First page :
A244
Section Title :
Infection
Open access? :
No
Section Order :
846